Page last updated: 2024-08-21

azomycin and Anemia

azomycin has been researched along with Anemia in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's3 (60.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andreeff, M; Benito, J; Borthakur, G; Bueso-Ramos, C; Cortes, J; Coveler, A; Daver, N; Estey, EH; Faderl, S; Feliu, J; Gu, Y; Gutheil, JC; Jabbour, E; Kadia, T; Kantarjian, H; Konoplev, S; Konopleva, M; Kornblau, S; Lu, H; Melink, TJ; Nguyen, HQ; Pemmaraju, N; Ravandi, F; Thall, PF; Thomas, D; Wei, C; Wilson, WR; Yi, CA1
Adkins, D; Butrynski, JE; Chawla, SP; Cranmer, LD; Ganjoo, KN; Kroll, S; Langmuir, VK; Lorente, G; Okuno, SH; Rushing, D1
Kertscho, H; Lauscher, P; Meier, J; Rosenberger, P; Schmidt, O; Zacharowski, K; Zimmermann, R1
Harrison, LB; Hu, K1
Chastagner, P; Fouyssac, F; Karcher, G; Pinel, S; Plenat, F; Poussier, S; Scigliano, S1

Reviews

1 review(s) available for azomycin and Anemia

ArticleYear
Impact of anemia in patients with head and neck cancer treated with radiation therapy.
    Current treatment options in oncology, 2005, Volume: 6, Issue:1

    Topics: Anemia; Cell Hypoxia; Erythropoietin; Head and Neck Neoplasms; Humans; Neoplasm Recurrence, Local; Nitroimidazoles; Prognosis; Quality of Life; Risk Factors; Survival Analysis

2005

Trials

2 trial(s) available for azomycin and Anemia

ArticleYear
Phase I/II study of the hypoxia-activated prodrug PR104 in refractory/relapsed acute myeloid leukemia and acute lymphoblastic leukemia.
    Haematologica, 2015, Volume: 100, Issue:7

    Topics: Adult; Aged; Anemia; Antigens, Neoplasm; Antineoplastic Agents, Alkylating; Biomarkers; Bone Marrow; Carbonic Anhydrase IX; Carbonic Anhydrases; Enterocolitis; Female; Gene Expression; Humans; Hypoxia; Hypoxia-Inducible Factor 1, alpha Subunit; Leukemia, Myeloid, Acute; Male; Middle Aged; Neutropenia; Nitrogen Mustard Compounds; Nitroimidazoles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prodrugs; Recurrence; Remission Induction; Thrombocytopenia

2015
A phase I study of the safety and pharmacokinetics of the hypoxia-activated prodrug TH-302 in combination with doxorubicin in patients with advanced soft tissue sarcoma.
    Oncology, 2011, Volume: 80, Issue:1-2

    Topics: Abscess; Adult; Aged; Aged, 80 and over; Anemia; Antineoplastic Combined Chemotherapy Protocols; Cellulitis; Disease-Free Survival; Doxorubicin; Drug Eruptions; Female; Granulocyte Colony-Stimulating Factor; Humans; Lymphopenia; Male; Maximum Tolerated Dose; Middle Aged; Neoadjuvant Therapy; Neutropenia; Nitroimidazoles; Phosphoramide Mustards; Sarcoma; Stomatitis; Treatment Outcome; Young Adult

2011

Other Studies

2 other study(ies) available for azomycin and Anemia

ArticleYear
Determination of organ-specific anemia tolerance.
    Critical care medicine, 2013, Volume: 41, Issue:4

    Topics: Acute Disease; Anemia; Animals; Brain; Cell Hypoxia; Female; Hemodilution; Hemodynamics; Hypoxia; Hypoxia, Brain; Immune Tolerance; Intestine, Small; Kidney; Liver; Male; Muscle, Skeletal; Nitroimidazoles; Oxygen Consumption; Random Allocation; Swine; Vascular Endothelial Growth Factor A

2013
Measurement of hypoxia using invasive oxygen-sensitive electrode, pimonidazole binding and 18F-FDG uptake in anaemic or erythropoietin-treated mice bearing human glioma xenografts.
    International journal of oncology, 2008, Volume: 32, Issue:1

    Topics: Anemia; Animals; Autoradiography; Electrodes; Erythropoietin; Fluorodeoxyglucose F18; Glioma; Hemoglobins; Humans; Hypoxia; Mice; Mice, Nude; Muscle, Skeletal; Neoplasm Transplantation; Nitroimidazoles; Recombinant Proteins; Transplantation, Heterologous

2008